| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |